Niagara-on-the-Lake’s latest draft of its new official plan is a solid starting point — one that has room for refinement, said the councillors and taxpayer association leaders who spoke with ...

Alexion Pharma Canada Corp., AstraZeneca's Rare Disease group, has entered into a Letter of Intent (LOI) with the pan-Canadian Pharmaceutical Alliance (pCPA) for Ultomiris (ravulizumab) for the ...